Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Half-Year 2021 Interim Results 2021-08-30 22:15
Everest Medicines Announces Up to HK$100 million Share Repurchase Program 2021-08-30 22:03
Alphamab Oncology Reports 2021 Interim Results and Business Highlights 2021-08-30 10:51
Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021 2021-08-30 08:00
Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer 2021-08-30 08:00
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs 2021-08-27 08:00
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million 2021-08-27 08:00
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions 2021-08-27 03:30
Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases 2021-08-27 03:22
Modern Chinese Medicine Announces Year 2021 Interim Results 2021-08-26 20:46
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 2021-08-26 20:00
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights 2021-08-26 19:56
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant 2021-08-26 19:50
CStone Pharmaceuticals Announces 2021 Interim Results 2021-08-26 19:14
Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint 2021-08-25 20:53
Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia 2021-08-25 19:25
Moolec Science and Grupo Insud Launch Food-Tech Joint Venture 2021-08-25 18:00
Extended Malaysian wound care tender: Bactiguard Holding 2021-08-25 15:49
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients 2021-08-25 08:42
Ascletis Announces Completion of the Bridging Study and Initiation of Phase II Trial of FXR Agonist ASC42 in China for Chronic Hepatitis B Indication 2021-08-25 08:30
1 108 109 110 111 112 230